Skip to main content


Browse the list below to see the latest scientific publications stemming from our institute faculty’s work. To view publications of specific AI faculty, please visit Membership and select a profile link.

  1. Machut KZ, Gilbart C, Murthy K, Michelson KN  A Qualitative Study of Nurses' Perspectives on Neonatologist Continuity of Care.  Adv Neonatal Care  2023 Oct 01;23(5):467-477. doi:10.1097/ANC.0000000000001096
  2. Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV  et al.  Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.  N Engl J Med  2023 Sep 21;389(12):1069-1084. doi:10.1056/NEJMoa2306963
  3. Gonzalez Sepulveda JM, Mehrotra S, Yang JC, Schantz KJ, Becker Y, Formica R, Ladner DP, Kaufman D, Friedewald J  Physician Preferences when Selecting Candidates for Lower-Quality Kidney Offers.  Clin J Am Soc Nephrol  2023 Sep 20;. doi:10.2215/CJN.0000000000000302
  4. Wehbe RM, Katsaggleos AK, Hammond KJ, Hong H, Ahmad FS, Ouyang D, Shah SJ, McCarthy PM, Thomas JD  Deep Learning for Cardiovascular Imaging: A Review.  JAMA Cardiol  2023 Sep 20;. doi:10.1001/jamacardio.2023.3142
  5. Narcisse DI, Kim H, Wruck LM, Stebbins AL, Muñoz D, Kripalani S, Effron MB, Gupta K, Anderson RD, Jain SK  et al.  Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial.  Diabetes Care  2023 Sep 15;. pii:dc230749
  6. Borlaug BA, Kitzman DW, Davies MJ, Rasmussen S, Barros E, Butler J, Einfeldt MN, Hovingh GK, Møller DV, Petrie MC  et al.  Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.  Nat Med  2023 Sep;29(9):2358-2365. doi:10.1038/s41591-023-02526-x
  7. Dey D, Arnaout R, Antani S, Badano A, Jacques L, Li H, Leiner T, Margerrison E, Samala R, Sengupta PP  et al.  Proceedings of the NHLBI Workshop on Artificial Intelligence in Cardiovascular Imaging: Translation to Patient Care.  JACC Cardiovasc Imaging  2023 Sep;16(9):1209-1223. doi:10.1016/j.jcmg.2023.05.012
  8. Bhatt AS, Lindholm D, Nilsson A, Zaozerska N, Claggett BL, Vaduganathan M, Kosiborod MN, Lam CSP, Hernandez AF, Martinez FA  et al.  Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.  Am Heart J  2023 Sep;263:133-140. doi:10.1016/j.ahj.2023.05.013
  9. Hitsman B, Papandonatos GD, Gollan JK, Huffman MD, Niaura R, Mohr DC, Veluz-Wilkins AK, Lubitz SF, Hole A, Leone FT  et al.  Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.  Addiction  2023 Sep;118(9):1710-1725. doi:10.1111/add.16209
  10. Eickelberg G, Sanchez-Pinto LN, Kline AS, Luo Y  Transportability of bacterial infection prediction models for critically ill patients.  J Am Med Inform Assoc  2023 Aug 30;. pii:ocad174
  11. Kondo T, Dewan P, Anand IS, Desai AS, Packer M, Zile MR, Pfeffer MA, Solomon SD, Abraham WT, Shah SJ  et al.  Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?  Circulation  2023 Aug 29;148(9):732-749. doi:10.1161/CIRCULATIONAHA.122.063642
  12. Chatur S, Vaduganathan M, Claggett BL, Cunningham JW, Docherty KF, Desai AS, Jhund PS, De Boer RA, Hernandez AF, Inzucchi SE  et al.  Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.  Circulation  2023 Aug 26;. doi:10.1161/CIRCULATIONAHA.123.066506
  13. Chatur S, Vaduganathan M, Claggett BL, Mc Causland FR, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN  et al.  Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to <25ml/min/1.73m2.  J Am Coll Cardiol  2023 Aug 23;. pii:S0735-1097(23)06532-4
  14. Verma S, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Dhingra NK, Kosiborod MN  A big STEP for treatment of heart failure with preserved ejection fraction.  Cell Metab  2023 Aug 17;. pii:S1550-4131(23)00298-X
  15. Chatur S, Vaduganathan M, Claggett B, Vardeny O, Desai AS, Jhund PS, de Boer RA, Lam CSP, Kosiborod MN, Shah SJ  et al.  Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.  Eur Heart J  2023 Aug 14;44(31):2930-2943. doi:10.1093/eurheartj/ehad283
  16. Basel Allaw M, Sinha A, Ghafourian K, Avery R, Weinberg RL, Lomasney JW, Shah SJ, Patel RB  Don't judge a book by its cover: a case report of apolipoprotein A-IV cardiac amyloidosis.  Eur Heart J Case Rep  2023 Aug;7(8):ytad341. pii:ytad341
  17. Friedman E, Baumann MJ, Sehgal S, Starren J, Steans R, Venables A, Michelson K  Pragmatic Research and Clinical Duties: Solutions Through Precision AI-Enabled Clinically Embedded Research.  Am J Bioeth  2023 Aug;23(8):50-52. doi:10.1080/15265161.2023.2217126
  18. Mao C, Xu J, Rasmussen L, Li Y, Adekkanattu P, Pacheco J, Bonakdarpour B, Vassar R, Shen L, Jiang G  et al.  AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease.  J Biomed Inform  2023 Aug;144:104442. doi:10.1016/j.jbi.2023.104442
  19. Wang H, Ding YJ, Luo Y  Future of ChatGPT in Pharmacovigilance.  Drug Saf  2023 Aug;46(8):711-713. doi:10.1007/s40264-023-01315-2
  20. Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Christensen L, Davies M, Hovingh KG, Kitzman DW, Lindegaard ML, Møller DV  et al.  Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype.  JACC Heart Fail  2023 Aug;11(8 Pt 1):1000-1010. doi:10.1016/j.jchf.2023.05.010
  21. Chatur S, Kondo T, Claggett BL, Docherty K, Miao ZM, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE  et al.  Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA-HF.  Eur J Heart Fail  2023 Aug;25(8):1364-1371. doi:10.1002/ejhf.2912
  22. Rong R, Sheng H, Jin KW, Wu F, Luo D, Wen Z, Tang C, Yang DM, Jia L, Amgad M  et al.  A Deep Learning Approach for Histology-Based Nucleus Segmentation and Tumor Microenvironment Characterization.  Mod Pathol  2023 Aug;36(8):100196. doi:10.1016/j.modpat.2023.100196
  23. Chuzi S, Tanaka Y, Bavishi A, Bruce M, Van Wagner LB, Wilcox JE, Ahmad FS, Ladner DP, Lagu T, Khan SS  Association Between End-Stage Liver Disease and Incident Heart Failure in an Integrated Health System.  J Gen Intern Med  2023 Aug;38(11):2445-2452. doi:10.1007/s11606-023-08199-z
  24. Litwin SE, Komtebedde J, Hu M, Burkhoff D, Hasenfuß G, Borlaug BA, Solomon SD, Zile MR, Mohan RC, Khawash R  et al.  Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction.  JACC Heart Fail  2023 Aug;11(8 Pt 2):1103-1117. doi:10.1016/j.jchf.2023.01.030
  25. Mitter SS, Shah SJ  HFpEF in Japan: When an Epidemiological Transition Becomes an Epidemiological Opportunity.  J Card Fail  2023 Aug;29(8):1228-1230. doi:10.1016/j.cardfail.2023.02.005
  26. Giro P, Cunningham JW, Rasmussen-Torvik L, Bielinski SJ, Larson NB, Colangelo LA, Jacobs DR, Gross M, Reiner AP, Lloyd-Jones DM  et al.  Missense Genetic Variation of ICAM1 and Incident Heart Failure.  J Card Fail  2023 Aug;29(8):1163-1172. doi:10.1016/j.cardfail.2023.02.003
  27. Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK, Harger G, Ho PM, Ahmad FS, Ahmad T  et al.  Clinical Inertia Among Outpatients With Heart Failure: Application of Treatment Nonintensification Taxonomy to EPIC-HF Trial.  JACC Heart Fail  2023 Jul 31;. pii:S2213-1779(23)00375-X
  28. Khan SS, Shah SJ  Pre-Heart Failure Risk Assessment: Don't Get Lost in an Echo Chamber!  J Card Fail  2023 Jul 31;. pii:S1071-9164(23)00266-X
  29. Naidech AM, Wang H, Hutch M, Murphy J, Paparello J, Bath P, Srivastava A, Luo Y  Blood pressure medication and acute kidney injury after intracerebral haemorrhage: an analysis of the ATACH-II trial.  BMJ Neurol Open  2023;5(2):e000458. pii:e000458
  30. Knapp AA, Hersch E, Wijaya C, Herrera MA, Kruzan KP, Carroll AJ, Lee S, Baker A, Gray A, Harris V  et al.  "The library is so much more than books": considerations for the design and implementation of teen digital mental health services in public libraries.  Front Digit Health  2023;5:1183319. pii:1183319
  31. Cousins HC, Kline AS, Wang C, Qu Y, Zengel J, Carette J, Wang M, Altman RB, Luo Y, Cong L  Integrative analysis of functional genomic screening and clinical data identifies a protective role for spironolactone in severe COVID-19.  Cell Rep Methods  2023 Jul 24;3(7):100503. pii:100503
  32. Wong AWK, Fong MWM, Munsell EGS, Metts CL, Lee SI, Nicol GE, DePaul O, Tomazin SE, Kaufman KJ, Mohr DC  Using Intervention Mapping and Behavior Change Techniques to Develop a Digital Intervention for Self-Management in Stroke: Development Study.  JMIR Hum Factors  2023 Jul 24;10:e45099. pii:e45099
  33. Lund LH, Lam CSP, Pizzato PE, Gabrielsen A, Michaëlsson E, Nelander K, Ericsson H, Holden J, Folkvaljon F, Mattsson A  et al.  Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.  Eur J Heart Fail  2023 Jul 20;. doi:10.1002/ejhf.2977
  34. Oakland HT, Shah SJ  Comprehensive Investigation of Latent Pulmonary Vascular Disease: An Important Exercise for a Novel HFpEF Phenotype.  JACC Heart Fail  2023 Jul 17;. pii:S2213-1779(23)00317-7
  35. Patel RB, Reddy VY, Komtebedde J, Wegerich SW, Sekaric J, Swarup V, Walton A, Laurent G, Chetcuti S, Rademann M  et al.  Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction.  JACC Heart Fail  2023 Jul 10;. pii:S2213-1779(23)00298-6
  36. Buyukcelebi K, Chen X, Abdula F, Elkafas H, Duval AJ, Ozturk H, Seker-Polat F, Jin Q, Yin P, Feng Y  et al.  Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization.  Nat Commun  2023 Jul 10;14(1):4057. pii:4057
  37. Zhao Z, Cao K, Watanabe J, Philips CN, Zeidner JM, Ishi Y, Wang Q, Gold SR, Junkins K, Bartom ET  et al.  Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations.  J Clin Invest  2023 Jul 03;133(13). pii:e169993
  38. Meyerhoff J, Liu T, Stamatis CA, Liu T, Wang H, Meng Y, Curtis B, Karr CJ, Sherman G, Ungar LH  et al.  Analyzing text message linguistic features: Do people with depression communicate differently with their close and non-close contacts?  Behav Res Ther  2023 Jul;166:104342. doi:10.1016/j.brat.2023.104342
  39. Canning C, Guo J, Narang A, Thomas JD, Ahmad FS  The Emerging Role of Artificial Intelligence in Valvular Heart Disease.  Heart Fail Clin  2023 Jul;19(3):391-405. doi:10.1016/j.hfc.2023.03.001
  40. Chatur S, Cunningham JW, Vaduganathan M, Mc Causland FR, Claggett BL, Desai AS, Miao ZM, Jhund PS, de Boer RA, Hernandez AF  et al.  Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.  Eur J Heart Fail  2023 Jul;25(7):1170-1175. doi:10.1002/ejhf.2915
  41. Peikert A, Chandra A, Kosiborod MN, Claggett BL, Desai AS, Jhund PS, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA  et al.  Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial.  JAMA Cardiol  2023 Jul 01;8(7):684-690. doi:10.1001/jamacardio.2023.1342
  42. Nassif ME, Windsor SL, Gosch K, Borlaug BA, Husain M, Inzucchi SE, Kitzman DW, McGuire DK, Pitt B, Scirica BM  et al.  Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials.  Circ Heart Fail  2023 Jul;16(7):e009837. doi:10.1161/CIRCHEARTFAILURE.122.009837
  43. Hoffmann AD, Weinberg SE, Swaminathan S, Chaudhuri S, Almubarak HF, Schipma MJ, Mao C, Wang X, El-Shennawy L, Dashzeveg NK  et al.  Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients.  Clin Immunol  2023 Jul;252:109634. doi:10.1016/j.clim.2023.109634
  44. Michaëlsson E, Lund LH, Hage C, Shah SJ, Voors AA, Saraste A, Redfors B, Grove EL, Barasa A, Richards AM  et al.  Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF.  JACC Heart Fail  2023 Jul;11(7):775-787. doi:10.1016/j.jchf.2023.03.002
  45. Bilaver LA, Wang H, Naidech AM, Luo Y, Das R, Sehgal S, Gupta R  Natural language processing of pediatric progress notes for the identification of food allergy.  J Allergy Clin Immunol Pract  2023 Jul;11(7):2242-2244.e2. doi:10.1016/j.jaip.2023.04.014
  46. Lutgendorf SK, Zia S, Luo Y, O'Donnell M, van Bokhoven A, Bradley CS, Gallup R, Pierce J, Taple BJ, Naliboff BD  et al.  Early and recent exposure to adversity, TLR-4 stimulated inflammation, and diurnal cortisol in women with interstitial cystitis/bladder pain syndrome: A MAPP research network study.  Brain Behav Immun  2023 Jul;111:116-123. doi:10.1016/j.bbi.2023.03.024
  47. Kou W, Soni P, Klug MW, Etemadi M, Kahrilas PJ, Pandolfino JE, Carlson DA  An artificial intelligence platform provides an accurate interpretation of esophageal motility from Functional Lumen Imaging Probe Panometry studies.  Neurogastroenterol Motil  2023 Jul;35(7):e14549. doi:10.1111/nmo.14549
  48. Prochaska JH, Jünger C, Schulz A, Arnold N, Müller F, Heidorn MW, Baumkötter R, Zahn D, Koeck T, Tröbs SO  et al.  Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus-results from the randomized, double-blind, placebo-controlled EmDia trial.  Clin Res Cardiol  2023 Jul;112(7):911-922. doi:10.1007/s00392-023-02164-w
  49. Sarma AA, Paniagua SM, Lau ES, Wang D, Liu EE, Larson MG, Hamburg NM, Mitchell GF, Kizer J, Psaty BM  et al.  Multiple Prior Live Births Are Associated With Cardiac Remodeling and Heart Failure Risk in Women.  J Card Fail  2023 Jul;29(7):1032-1042. doi:10.1016/j.cardfail.2022.12.014
  50. Yang M, Goh V, Lee J, Espinoza M, Yuan Y, Carns M, Aren K, Chung L, Khanna D, McMahan ZH  et al.  Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin.  Arthritis Care Res (Hoboken)  2023 Jul;75(7):1469-1480. doi:10.1002/acr.24998